TLC Eligibility Screener

Evaluation of TransLife Center (TLC): A Locally-Developed Combination Prevention Intervention for Transgender Women at High Risk of HIV Infection

Appendix B Eligibility Screener_COVID_21Sept2020_clean

Eligibility Screening

OMB: 0920-1246

Document [docx]
Download: docx | pdf

Form Approved

OMB No. 0920 – 1246

Expiration Date: 10/31/2021













Evaluation of TransLife Center (TLC): A Locally-Developed Combination Prevention

Intervention for Transgender Women at High Risk of HIV Infection


Attachment 4a

TLC Eligibility Screener












Privacy Act Statement:

This information is collected under the authority of the Public Health Service Act, Section 301, "Research and Investigation," (42 U.S.C. 241); and Sections 304, 306 and 308(d) which discuss authority to maintain data and provide assurances of confidentiality for health research and related activities (42 U.S.C. 242 b, k, and m(d)).  This information is also being collected in conjunction with the provisions of the Government Paperwork Elimination Act and the Paperwork Reduction Act (PRA). This information will only be used by the Centers for Disease Control and Prevention (CDC) staff to evaluate TransLife Center (TLC) as an HIV prevention intervention for transgender women.




Public reporting burden of this collection of information is estimated to average 4 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-New)

Hi, My name is (name) and I’m one of the staff members working on the Trans Life Care study, also known as the TLC study, which is being conducted at Chicago House and Social Service Agency (Chicago House), in collaboration with Ann & Robert H. Lurie Children’s Hospital of Chicago (Lurie Children’s). The TLC offers supportive services to transgender women, such as help with housing, employment, legal and medical services. The purpose of this study is to see if the TLC helps prevent HIV and other infections in trans women. You will be compensated for your time and effort as part of this study. Are you interested in hearing more about it?

Response: If yes, continue. If no, thank them for their time and discontinue screening.

If you are eligible and decide to join this study, you will be in it for up to 8 months. Due to restrictions associated with the COVID-19 pandemic, participation will include access to web and telephone-based services at the TLC, and some limited in-person services, such as HIV testing. At the first visit, we will ask you to complete an HIV test and an evaluation questionnaire on a computer. The questionnaire asks about your experiences with sex, alcohol and drugs, health care and mental health, and your experience as a transgender woman. We will ask you to complete questionnaires again in 4 months and then 8 months. You will have the choice to complete your questionnaires and an initial HIV test in the offices at Chicago House with COVID-19 restrictions or remotely. If you choose to enroll remotely, we will deliver an HIV home test to you and you will complete the initial questionnaire on your own, at home.

You will receive $50 each time you complete the questionnaire at each of 3 study visits, for a total of up to $150 for completion of all questionnaires.

If you are eligible and decide to participate we will keep all information we collect from you private, and only the evaluation team will have access to this information. We will need to ask you for contact information so that we can invite you to complete follow-up assessments.

Please remember that participation in the study, including answering any of the screening questions, is completely voluntary. You can refuse to answer any of the questions or decide that you do not want to participate in the study at any time. You can also decide to participate in TLC services, but not the study component. If you have questions about this study, you can contact the Principal Investigator, Judy Perloff or the Coordinator of the TLC at Chicago House at 773-248-5200 or the Principal Investigator at Lurie Children’s, Lisa Kuhns at (312) 227-7760.

To find out if you’re eligible to participate in this study, I’ll need to take about 4 minutes to ask you some questions. Some of these questions are quite personal and sensitive; however, your answers to these questions will be kept private. One of the reasons we stress privacy is that we do ask some very personal questions, and it is very important that you be as honest and as accurate as you can be with your answers. It is only if you are eligible and interested in participating that I will ask for your name and contact information. Your contact information will be stored separately from your answers to this questionnaire and be linked only by an identification number.


Answering these questions is completely voluntary. You can choose not to screen for this study if you don’t want to. Whether you choose to screen for this study or not will not impact your relationship with Chicago House or Lurie Children’s or any staff of either organization. Are you willing to answer some questions to determine if you are eligible for the study?





Response: If yes, continue with Screening Questions. If no, ask for reasons why:


No interest . . . . . . . . . . . . . . . . . . . . 01

Worried about anonymity . . . . . . . . 02

Project takes too long . . . . . . . . . . . . 03

Afraid of evaluation/guinea-pig . . . . . 04

Rather not say . . . . . . . . . . . . . . . . . 05

Other . . . . . . . . . . . . . . . . . . . . . . . . 06

If other, specify __________________________________


Thank the participant for their time.


INSTRUCTIONS: Participant ID numbers will only be assigned (a) after the screening questions determine the volunteer to be eligible for this study and (b) after the participant signs the consent form. Regardless of whether or not the volunteer is eligible, record their responses to all questions.



1. First, how did you find out about this project?

Brochure/flyer/sign: _____________________

Recruited by project staff: _____________________

Community event (parade, street fair, etc.): ___________________

Counseling and testing program: _____________________

Community based organization/agency: ______________________

Friend/family: __________________________

Other, specify: _________________________



2. How old were you at your last birthday?

|_____|_____| years (If not at least 17 years old, check ineligible and continue) Ineligible


3. What sex were you assigned at birth, on your original birth certificate*?

Male

Female

Refused

Don’t know

* Very nearly everyone is assigned a sex at birth – including persons with Disorders of Sex Development (DSDs) who are sometimes called Intersex. If a respondent mentions this, ask them again what their birth certificate says. If they are unclear or unsure, they are ineligible.


4. Do you currently describe yourself as male, female, or transgender?

Male

Female

Transgender

None of these


5. Just to confirm, you were assigned [FILL from #3] at birth, and now describe yourself as [FILL from #4]. Is that correct?

Yes

No

Refused

Don’t know




Assess combination of response to 3, 4 and 5, eligible participants must self-identify as transgender with a birth sex of male. Talking through these responses is expected, as many women who are eligible may respond to both 3 & 4 as Female. Remind participants that this project is for trans women.


If participant does not meet sex/gender identity requirements,

check ineligible and continue Ineligible



5. Have you had sex with a man in the past 4 months?

Yes

No

Don’t know/refused

If “No” or “Don’t know/refused” check ineligible and continue Ineligible



6. What was the result of your most recent HIV test?

Never tested

Positive

Negative

Indeterminate

Don’t know/refused


If “Positive,” check ineligible and continue Ineligible


  1. Are you able to speak and understand English?

Yes

No (Check ineligible and continue) Ineligible



  1. Have you received services through the TLC in the past 4 months?

Yes (Check ineligible and continue) Ineligible

No



  1. Do you plan on staying in the Chicago area for the next 8 months?

Yes

No (Check ineligible and continue) Ineligible








Questions 10-13 are for the interviewer only.

DO NOT ASK THESE QUESTIONS OF THE VOLUNTEERS.


  1. Does the volunteer seem cognitively functioning and able to understand the assent/consent process?

Yes

No (Check ineligible and continue) Ineligible (If ineligible based on this criterion, refer to supervisor to conduct ineligible script and provide referral.)



  1. Does the volunteer seem distraught or emotionally unstable (i.e. suicidal, manic, exhibiting violent behavior)?

Yes (Check ineligible and continue)

No Ineligible (If ineligible based on this criterion, refer to supervisor to conduct ineligible script and provide referral.)



  1. Does the volunteer seem intoxicated or under the influence of psychoactive agents?

Yes (Check ineligible)

No Ineligible (If ineligible based on this criterion, refer to supervisor to conduct ineligible script and provide referral.)


  1. Aside from eligibility criteria, does the volunteer appear to be a good fit for the study?

Yes

No (Check ineligible and briefly explain below) Ineligible (If ineligible based on this criterion, refer to supervisor to conduct ineligible script and provide referral.)

INSTRUCTIONS: If any of the above ineligible boxes are checked, read the INELIGIBLE script. If none of the ineligible boxes are checked, read the ELIGIBLE script below.


SCRIPT For INELIGIBLE volunteers:

Participants in this study are selected based on the questions you were just asked. Based on your answers, it turns out you’re not eligible to participate in the study. Would you be interested in being contacted for other programs or research studies that you may be eligible for or if the eligibility criteria for this study changes in the future?


No (Thank volunteer and end interview)

Yes (Fill out contact information)



Script for ELIGIBLE volunteers:

Thank you very much for the information you provided. Based on your answers to these questions, you are eligible to participate in this study.


To participate in this study, you will be asked to complete questionnaires and an initial HIV test in the offices at Chicago House with COVID-19 restrictions or remotely. To determine if you can participate in a remote visit, please answer the following questions:


  1. Do you have access to a smart phone, laptop, or another device that you can use to participate in a video call (e.g., Skype, FaceTime, Zoom) with a Chicago House staff member?

Yes

No

  1. Do you have access to data/WiFi so that you can participate in a video call with a Chicago House staff member?

Yes

No

  1. Do you have someplace private (like your apartment, your room) where you can participant in a video call to with a Chicago House staff member?

Yes

No

  1. Do you have an email address that you can check during the video call where we will send the questionnaires and other information?

Yes

No

  1. Are you comfortable with completing a home HIV test that a Chicago House staff member delivers to you? You will complete the test with a Chicago House staff member on the video call and they will counsel you through the test as they would if you came into our offices.

Yes

No



INSTRUCTIONS: If any of the above boxes are checked “no”, read the ONSITE VISIT script. If all of the boxes are checked “yes”, read the ONSITE/REMOTE VISIT script below.


ONSITE VISIT SCRIPT

You are eligible to enroll in this study if you come to the Chicago House office now located at 2229 S. Michigan Avenue, Suite 304, Chicago, Illinois, in the South Loop to enroll.


Are you interested in taking part in this study?


Response: If “NO”, thank them for their time. If “YES”:


Great! Before we go any further, I need to get your name and then schedule an appointment with you to complete the initial appointment. (continue to scheduling sheet)



ONSITE/REMOTE SCRIPT

You are eligible to enroll in this study either by coming to the Chicago House office now located at 2229 S. Michigan Avenue, Suite 304, Chicago, Illinois, in the South Loop to enroll, or by completing a remote visit. If you choose to enroll remotely, we will deliver an HIV home test to you and you will complete the initial questionnaire at your home. Part of the visit will be conducted by a Chicago House staff member via a video call and we will email you the questionnaires and other information.



Are you interested in taking part in this study?


Response: If “NO”, thank them for their time. If “YES”:


Would you prefer to complete the enrollment visit by coming into the offices at Chicago House with COVID-19 restrictions or remotely from your home via a video call?


Onsite at Chicago House

Remotely at home




Great! Before we go any further, I need to get your name and then schedule an appointment with you to complete the initial appointment.

THE INFORMATION BELOW INCLUDES IDENTIFYING INFORMATION, STORE SEPERATELY FROM SCREENING DATA.



Preferred name (name you go by): ______________________


Preferred pronoun (she/her, he/him, etc): _____________



What’s a good time for you to come in? |_____|_____|--|_____|_____| at ____ ____:____ ____ AM / PM


And if we miss you at that time, what’s a good way to contact you to follow up?


Phone: _________________________ Ok to LVM?


  1. What name should we use to ask for you at this number? _____________________

  2. What pronoun should we use to ask for you at this number? _________________


Email: Ok to email?

Facebook: Ok to message?


_____ Initials of person completing this screening form


Entered into screening database


_____ Initials of person entering information into screening database


13


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorBessler, Patricia (CDC/OID/NCHHSTP)
File Modified0000-00-00
File Created2021-01-13

© 2024 OMB.report | Privacy Policy